Articles related to COVID-19

The FDA’s recent update to Paxlovid’s EUA ensures a seamless transition to NDA-labeled nirmatrelvir+ritonavir for treating high-risk pediatric patients, reflecting a commitment to adaptability and patient care in the ongoing fight against COVID-19.

Guidelines from the CDC and AHA emphasize the critical role of vaccinations in protecting cardiac patients against the heightened risk of severe complications from infections like influenza and RSV, advocating for a comprehensive vaccination strategy.

In a revealing study, researchers found a higher incidence of long-COVID symptoms in patients who received two COVID-19 vaccine doses, challenging previous perceptions and highlighting the need for deeper understanding in post-COVID care.

New research suggests that the COVID-19 virus and its remnant spike protein may bind to and kill lymphocytes, leading to lymphopenia.

A recent study found a 69 percent increased risk of Alzheimer’s diagnosis within a year of COVID-19 infection in individuals aged 65 years and older. This significant link between viral infections and Alzheimer’s disease could have major implications for our understanding of neurodegenerative diseases and their treatment.

The escalating crisis of burnout among oncology healthcare workers is a pressing issue that demands immediate attention. With up to 54% of doctors and nurses experiencing burnout, the need for systemic changes in the healthcare landscape has never been more urgent.